133 related articles for article (PubMed ID: 16314615)
1. Comparison of ABVD and alternating or hybrid multidrug regimens for the treatment of advanced Hodgkin's lymphoma: results of the United Kingdom Lymphoma Group LY09 Trial (ISRCTN97144519).
Johnson PW; Radford JA; Cullen MH; Sydes MR; Walewski J; Jack AS; MacLennan KA; Stenning SP; Clawson S; Smith P; Ryder D; Hancock BW;
J Clin Oncol; 2005 Dec; 23(36):9208-18. PubMed ID: 16314615
[TBL] [Abstract][Full Text] [Related]
2. Comparison of first-line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma.
Skoetz N; Will A; Monsef I; Brillant C; Engert A; von Tresckow B
Cochrane Database Syst Rev; 2017 May; 5(5):CD007941. PubMed ID: 28541603
[TBL] [Abstract][Full Text] [Related]
3. Advanced Hodgkin lymphoma in the East of England: a 10-year comparative analysis of outcomes for real-world patients treated with ABVD or escalated-BEACOPP, aged less than 60 years, compared with 5-year extended follow-up from the RATHL trial.
Russell J; Collins A; Fowler A; Karanth M; Saha C; Docherty S; Padayatty J; Maw K; Lentell I; Cooke L; Hodson A; Shah N; Sadullah S; Grigoropoulos N; Qian W; Kirkwood AA; Uttenthal BJ; Johnson P; Follows GA
Ann Hematol; 2021 Apr; 100(4):1049-1058. PubMed ID: 33641019
[TBL] [Abstract][Full Text] [Related]
4. Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma.
Connors JM; Jurczak W; Straus DJ; Ansell SM; Kim WS; Gallamini A; Younes A; Alekseev S; Illés Á; Picardi M; Lech-Maranda E; Oki Y; Feldman T; Smolewski P; Savage KJ; Bartlett NL; Walewski J; Chen R; Ramchandren R; Zinzani PL; Cunningham D; Rosta A; Josephson NC; Song E; Sachs J; Liu R; Jolin HA; Huebner D; Radford J;
N Engl J Med; 2018 Jan; 378(4):331-344. PubMed ID: 29224502
[TBL] [Abstract][Full Text] [Related]
5. Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival: individual participant data analysis.
Franklin J; Eichenauer DA; Becker I; Monsef I; Engert A
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD008814. PubMed ID: 28901021
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Follow-Up of the Response-Adapted Intergroup EORTC/LYSA/FIL H10 Trial for Localized Hodgkin Lymphoma.
Federico M; Fortpied C; Stepanishyna Y; Gotti M; van der Maazen R; Cristinelli C; Re A; Plattel W; Lazarovici J; Merli F; Specht L; Schiano de Colella JM; Hutchings M; Versari A; Edeline V; Stamatoulas A; Girinsky T; Ricardi U; Aleman B; Meulemans B; Tonino S; Raemaekers J; André M
J Clin Oncol; 2024 Jan; 42(1):19-25. PubMed ID: 37967311
[No Abstract] [Full Text] [Related]
7. Positron Emission Tomography Score Has Greater Prognostic Significance Than Pretreatment Risk Stratification in Early-Stage Hodgkin Lymphoma in the UK RAPID Study.
Barrington SF; Phillips EH; Counsell N; Hancock B; Pettengell R; Johnson P; Townsend W; Culligan D; Popova B; Clifton-Hadley L; McMillan A; Hoskin P; O'Doherty MJ; Illidge T; Radford J
J Clin Oncol; 2019 Jul; 37(20):1732-1741. PubMed ID: 31112475
[TBL] [Abstract][Full Text] [Related]
8. Acute liver failure secondary to ABVD use.
Eslami A; Mathur AD; Jha KK; Wang H
BMJ Case Rep; 2018 Jul; 2018():. PubMed ID: 30061135
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Follow-Up of the Response-Adjusted Therapy for Advanced Hodgkin Lymphoma Trial.
Luminari S; Fossa A; Trotman J; Molin D; d'Amore F; Enblad G; Berkahn L; Barrington SF; Radford J; Federico M; Kirkwood AA; Johnson PWM
J Clin Oncol; 2024 Jan; 42(1):13-18. PubMed ID: 37883739
[No Abstract] [Full Text] [Related]
10. Outcomes in adolescents and young adults with Hodgkin lymphoma treated on US cooperative group protocols: An adult intergroup (E2496) and Children's Oncology Group (COG AHOD0031) comparative analysis.
Henderson TO; Parsons SK; Wroblewski KE; Chen L; Hong F; Smith SM; McNeer JL; Advani RH; Gascoyne RD; Constine LS; Horning S; Bartlett NL; Shah B; Connors JM; Leonard JI; Kahl BS; Kelly KM; Schwartz CL; Li H; Friedberg JW; Friedman DL; Gordon LI; Evens AM
Cancer; 2018 Jan; 124(1):136-144. PubMed ID: 28902390
[TBL] [Abstract][Full Text] [Related]
11. Improved survival of children and adolescents with classical Hodgkin lymphoma treated on a harmonised protocol in South Africa.
Geel J; van Zyl A; Plessis JD; Hendricks M; Goga Y; Carr A; Neethling B; Hramyka A; Omar F; Mathew R; Louw L; Naidoo T; Ngcana T; Schickerling T; Netshituni V; Madzhia E; du Plessis L; Kelsey T; Ballot DE; Metzger ML
Pediatr Blood Cancer; 2024 Jan; 71(1):e30712. PubMed ID: 37814417
[TBL] [Abstract][Full Text] [Related]
12. Response-dependent and reduced treatment in lower risk Hodgkin lymphoma in children and adolescents, results of P9426: a report from the Children's Oncology Group.
Tebbi CK; Mendenhall NP; London WB; Williams JL; Hutchison RE; Fitzgerald TJ; de Alarcón PA; Schwartz C; Chauvenet A
Pediatr Blood Cancer; 2012 Dec; 59(7):1259-65. PubMed ID: 22911615
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Hodgkin Lymphoma With ABVD Chemotherapy in Rural Rwanda: A Model for Cancer Care Delivery Implementation.
DeBoer RJ; Shyirambere C; Driscoll CD; Butera Y; Paciorek A; Ruhangaza D; Fadelu TA; Umwizerwa A; Bigirimana JB; Muhayimana C; Nguyen C; Park PH; Mpunga T; Lehmann L; Shulman LN
JCO Glob Oncol; 2020 Jul; 6():1093-1102. PubMed ID: 32678711
[TBL] [Abstract][Full Text] [Related]
14. The Impact of Bleomycin Deficit on Survival in Hodgkin's Lymphoma Patients: A Retrospective Study.
Soldi LR; Rabelo DH; da Silva PHR; Silva VLC; Silva MJB
Cancer Treat Res Commun; 2024; 38():100790. PubMed ID: 38241969
[TBL] [Abstract][Full Text] [Related]
15. Pregnancy after treatment of secondary acute promyelocytic leukemia following Hodgkin's disease: a case report.
Elezović I; Colović M; Tomin D; Bosković D
Med Oncol; 2000 Aug; 17(3):222-4. PubMed ID: 10962534
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of brentuximab vedotin in advanced stage Hodgkin's lymphoma: a probabilistic analysis.
Raymakers AJN; Costa S; Cameron D; Regier DA
BMC Cancer; 2020 Oct; 20(1):992. PubMed ID: 33050897
[TBL] [Abstract][Full Text] [Related]
17. Long-term results of CCG 5942: a randomized comparison of chemotherapy with and without radiotherapy for children with Hodgkin's lymphoma--a report from the Children's Oncology Group.
Wolden SL; Chen L; Kelly KM; Herzog P; Gilchrist GS; Thomson J; Sposto R; Kadin ME; Hutchinson RJ; Nachman J
J Clin Oncol; 2012 Sep; 30(26):3174-80. PubMed ID: 22649136
[TBL] [Abstract][Full Text] [Related]
18. Advanced stage anaplastic large cell lymphoma in children and adolescents: results of ANHL0131, a randomized phase III trial of APO versus a modified regimen with vinblastine: a report from the children's oncology group.
Alexander S; Kraveka JM; Weitzman S; Lowe E; Smith L; Lynch JC; Chang M; Kinney MC; Perkins SL; Laver J; Gross TG; Weinstein H
Pediatr Blood Cancer; 2014 Dec; 61(12):2236-42. PubMed ID: 25156886
[TBL] [Abstract][Full Text] [Related]
19. Gene expression-based model using formalin-fixed paraffin-embedded biopsies predicts overall survival in advanced-stage classical Hodgkin lymphoma.
Scott DW; Chan FC; Hong F; Rogic S; Tan KL; Meissner B; Ben-Neriah S; Boyle M; Kridel R; Telenius A; Woolcock BW; Farinha P; Fisher RI; Rimsza LM; Bartlett NL; Cheson BD; Shepherd LE; Advani RH; Connors JM; Kahl BS; Gordon LI; Horning SJ; Steidl C; Gascoyne RD
J Clin Oncol; 2013 Feb; 31(6):692-700. PubMed ID: 23182984
[TBL] [Abstract][Full Text] [Related]
20. Estimated impact of ECHELON-1 overall survival on productivity costs in stage III/IV classical Hodgkin lymphoma in the United States.
Phillips T; Liu N; Bloudek B; Migliaccio-Walle K; Reynolds J; Burke JM
J Manag Care Spec Pharm; 2023 Dec; 29(12):1312-1320. PubMed ID: 37921077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
